OpenScience.ink

2 weeks ago • European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society

Possible effects of glucagon-like peptide-1 receptor drugs on recovery after spine surgeryCan glucagon-like peptide-1 receptor agonists affect outcomes after spine surgery? A systematic review and meta-analysis.

📖 Top 20% Journal

2 weeks ago • Multiple sclerosis and related disorders

GLP-1 receptor drugs and their potential in multiple sclerosis: a review of laboratory and patient studiesGLP-1 receptor agonists in multiple sclerosis: a systematic review of preclinical and clinical evidence.

📖 Top 20% Journal

2 weeks ago • Obesity surgery

Best Time to Start GLP-1 Treatment for Obese Patients Considering Weight-Loss SurgeryOptimal Timing of GLP-1 Receptor Agonist Initiation in Patients with Obesity Eligible for Metabolic Bariatric Surgery.

📖 Top 20% Journal

2 weeks ago • Cell reports

Modified GLP1R activators favor G protein signaling by shifting a specific outer receptor loopN-terminally modified GLP1R agonists drive G protein bias via extracellular loop 3 displacement.

🥈 Top 2% Journal

2 weeks ago • Journal of the American Heart Association

🥉 Top 5% Journal

2 weeks ago • Surgical endoscopy

Changes in weight-loss surgery use after semaglutide and tirzepatide became popularEvolving utilization of bariatric surgery since the rise of semaglutide and tirzepatide.

📖 Top 20% Journal

2 weeks ago • Journal of translational medicine

Tirzepatide as a treatment for kidney problems in obesity: findings from real-world useTirzepatide as a therapeutic tool for kidney impairment in obesity: insights from a real-world study.

🥉 Top 5% Journal

2 weeks ago • JAMA health forum

Compounded GLP-1 Receptor Agonist Use After Shortages in Two States with Likely High DemandPostshortage Compounded GLP-1 RA Market in 2 States With Potentially High Demand.

🥉 Top 5% Journal

2 weeks ago • BMC endocrine disorders

Short-term tirzepatide treatment and its link to average platelet size in people with obesityEffect of short-term tirzepatide treatment on mean platelet volume in patients with obesity: a retrospective controlled study.

📖 Top 20% Journal

2 weeks ago • RMD open

Potential role of GLP-1 receptor agonists in treating systemic lupus erythematosusGLP-1 receptor agonists in systemic lupus erythematosus: a scoping review.

🎖️ Top 10% Journal

2 weeks ago • Circulation research

Protecting the Heart by Preventing Blood Vessel Aging with GLP-1 Receptor AgonistsPrevention of Vascular Aging as a Novel Paradigm for GLP-1 Receptor Agonist-Mediated Cardioprotection.

🥇 Top 1% Journal

2 weeks ago • Circulation research

GLP-1 Receptor Agonists: From Effective Treatments to Understanding How They WorkGLP-1 Receptor Agonists: From Clinical Success to Mechanistic Insight.

🥇 Top 1% Journal

2 weeks ago • Biological psychiatry

How GLP-1 Influences Alcohol-Related Behaviors in Animal StudiesGLP-1 and Alcohol-Related Behaviors: Insights From Preclinical Studies.

🥈 Top 2% Journal

3 weeks ago • BMJ open gastroenterology

How GLP-1-based treatment relates to small bowel movement speed during capsule endoscopyAssociation between GLP-1-based therapy and small-bowel transit time during capsule endoscopy: a prospective, multicentre, observational study.

📖 Top 20% Journal

3 weeks ago • The lancet. Gastroenterology & hepatology

Safety and effectiveness of zalfermin with semaglutide in people with liver scarring from metabolic-related fatty liver disease: a phase 2 dose studyEfficacy and safety of zalfermin co-administered with semaglutide in participants with fibrosis and cirrhosis due to metabolic dysfunction-associated steatohepatitis: a phase 2, dose-ranging, double-blind, randomised controlled trial.

🥇 Top 1% Journal

3 weeks ago • Diabetes technology & therapeutics

New Cases of Diabetic Eye Disease After One Year of Adding Tirzepatide in Adults with Type 1 DiabetesIncident Diabetic Retinopathy after Adjunctive Tirzepatide Treatment for 1 Year in Adults with Type 1 Diabetes.

🥈 Top 2% Journal

3 weeks ago • Obesity surgery

Best time to start Liraglutide 3.0 mg for patients with ongoing obesity six months after weight-loss surgeryOptimal Timing for Initiating Liraglutide 3.0 mg in Patients With Persistent Obesity Six Months After Metabolic and Bariatric Surgery.

📖 Top 20% Journal

3 weeks ago • Diabetes

How GIP Medicine Affects Insulin, Glucagon, and Heart Responses During High Blood Sugar in Type 2 DiabetesEffects of Pharmacological GIP Infusion on Insulin, Glucagon, and Cardiovascular Responses During Hyperglycemia in Type 2 Diabetes.

🥉 Top 5% Journal

3 weeks ago • Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

Cancer risk of weight-loss drugs that activate the glucagon-like peptide-1 receptor compared to bariatric surgery and other treatmentsCancer risk of glucagon-like peptide-1 receptor agonists for obesity: comparison with bariatric surgery and other weight-loss drugs.

📖 Top 20% Journal

3 weeks ago • International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Glucagon-like peptide-1 receptor agonist and opioid use after gynecologic surgeryGlucagon-like peptide-1 receptor agonist and post-operative opioid consumption in gynecologic surgery.

🎖️ Top 10% Journal

3 weeks ago • Nature reviews. Endocrinology

How Fat Detection and Brain Hormones Influence Eating and Blood Sugar ControlLipid sensing and brain hormone receptors in food intake and glucose regulation.

🥇 Top 1% Journal

3 weeks ago • World journal of surgery

Use of GLP-1 Receptor Agonists Around Breast Cancer Surgery and 30-Day Recovery OutcomesPerioperative GLP-1 Receptor Agonist Use and 30-Day Outcomes After Breast Cancer Surgery: A Retrospective Cohort Study.

📖 Top 30% Journal

← prevpage 7 of 14next →

GLP-1 Therapies Research Papers